Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The purpose of this study is
to test whether biphasic insulin aspart 70/30 is a safe and at least as effective alternative
in combination with two oral anti-diabetics compared to the two oral anti-diabetics alone for
the control of blood glucose.